Dyax Corporation (DYAX)
Create an Alert
3.29
+0.06 +1.86%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Dyax Corporation Book Value:
-59.82M for March 31, 2013Dyax Corporation Historical Book Value Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -59.82M |
| Dec. 31, 2012 | -51.56M |
| Sept. 30, 2012 | -48.36M |
| June 30, 2012 | -44.41M |
| March 31, 2012 | -37.83M |
| Dec. 31, 2011 | -27.40M |
| Sept. 30, 2011 | -14.84M |
| June 30, 2011 | -5.983M |
| March 31, 2011 | -7.197M |
| Dec. 31, 2010 | 2.633M |
| Sept. 30, 2010 | 10.50M |
| June 30, 2010 | 20.41M |
| March 31, 2010 | 15.23M |
| Dec. 31, 2009 | -38.60M |
| Sept. 30, 2009 | -49.20M |
| June 30, 2009 | -37.84M |
| March 31, 2009 | -41.88M |
| Dec. 31, 2008 | -20.04M |
| Sept. 30, 2008 | -27.97M |
| June 30, 2008 | -14.42M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Book Value of Equity
YCharts' book value of equity is the equivalent of total assets less total liabilities and preferred equity.
The book value of equity represents the equity of shareholders (from a balance sheet perspective) less the preferred stock.
Learn More
DYAX Book Value Benchmarks
| Companies | |
|---|---|
| Amgen | 19.49B |
| ARCA biopharma | 3.311M |
| Halozyme Therapeutics | 31.68M |
DYAX Book Value Rankings
| Overall |
42nd percentile 9720 of 16782 |
| Sector |
30th percentile 976 of 1410 in Healthcare |
| Industry |
26th percentile 334 of 454 in Biotechnology |
DYAX Book Value Range, Past 5 Years
| Minimum | -59.82M | Mar 2013 |
| Maximum | 20.41M | Jun 2010 |
| Average | -23.93M |
